Search Count: 28
![]() |
Organism: Human papillomavirus 16, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-08-20 Classification: IMMUNE SYSTEM |
![]() |
Organism: Human papillomavirus 16, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-08-20 Classification: IMMUNE SYSTEM |
![]() |
Organism: Human papillomavirus 16, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-08-20 Classification: IMMUNE SYSTEM |
![]() |
4-(2-Isothiocyanatoethyl)Phenol Inhibitor Complexed With Macrophage Migration Inhibitory Factor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2014-03-12 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 4MT, SO4, CL, IPA |
![]() |
Multiple Binding Modes Of Benzyl Isothiocyanate Inhibitor Complexed With Macrophage Migration Inhibitory Factor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2014-03-05 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 9BE, SO4, GOL, CL |
![]() |
Allyl Isothiocyanate Inhibitor Complexed With Macrophage Migration Inhibitory Factor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2014-03-05 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 9AI, SO4, IPA, CL, GOL |
![]() |
Multiple Binding Modes Of Benzyl Isothiocyanate Inhibitor Complexed With Macrophage Migration Inhibitory Factor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2014-03-05 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 9BE, SO4, IPA |
![]() |
(6-Isothiocyanatohexyl)Benzene Inhibitor Complexed With Macrophage Migration Inhibitory Factor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-03-05 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 1X2, SO4, GOL |
![]() |
Organism: Streptococcus intermedius, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.49 Å Release Date: 2013-05-08 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2007-08-07 Classification: LIPID BINDING PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.34 Å Release Date: 2007-08-07 Classification: MEMBRANE PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2007-08-07 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2007-01-02 Classification: TRANSFERASE Ligands: 5I5 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2007-01-02 Classification: TRANSFERASE Ligands: 89I |
![]() |
Organism: Escherichia coli
Method: SOLUTION NMR Release Date: 2005-01-11 Classification: STRUCTURAL PROTEIN |
![]() |
Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2004-01-07 Classification: REGULATOR OF COMPLEMENT PATHWAY Ligands: ACT, SO4, GOL |
![]() |
Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2004-01-07 Classification: REGULATOR OF COMPLEMENT PATHWAY Ligands: SO4, GOL |
![]() |
Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2004-01-07 Classification: REGULATOR OF COMPLEMENT PATHWAY Ligands: ACT, GOL, SO4 |
![]() |
Decay Accelerating Factor (Cd55) : The Structure Of An Intact Human Complement Regulator.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2004-01-07 Classification: REGULATOR OF COMPLEMENT PATHWAY Ligands: ACT, GOL, SO4 |
![]() |
Decay Accelerating Factor (Cd55): The Structure Of An Intact Human Complement Regulator.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2004-01-07 Classification: REGULATOR OF COMPLEMENT PATHWAY Ligands: ACT, SO4, GOL |




















